Profile data is unavailable for this security.
About the company
Everest Medicines Ltd is a China-based company principally engaged in the licensing, clinical development and commercialization of therapies to address critical unmet medical needs. The Company is focusing on the research and development of innovative drug candidate. The Company built a portfolio of promising clinical-stage drug candidates across oncology, immunology, cardio-renal disease and infectious disease. The Company mainly provides its products and services in Greater China and other emerging Asia Pacific markets.
- Revenue in HKD (TTM)1.21m
- Net income in HKD-1.42bn
- Incorporated2017
- Employees476.00
- LocationEverest Medicines Ltd1266 West Nanjing RoadPlaza 66, Tower 1, Units 6601-6606SHANGHAI 200040ChinaCHN
- Websitehttp://www.everestmedicines.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dawnrays Pharmaceutical Holdings Ltd | 1.30bn | 400.02m | 1.60bn | 1.06k | 4.03 | 0.5888 | 3.44 | 1.23 | 0.2654 | 0.2654 | 0.8623 | 1.82 | 0.3839 | 2.39 | 7.00 | 1,220,386.00 | 11.72 | 11.45 | 13.95 | 13.83 | 59.26 | 58.71 | 30.53 | 29.60 | 2.31 | 20.12 | 0.0105 | 42.68 | 13.75 | 7.17 | 33.58 | 6.14 | 65.21 | 2.29 |
| Jacobson Pharma Corporation Ltd | 1.60bn | 177.67m | 1.68bn | 1.74k | 9.38 | 0.669 | 4.42 | 1.05 | 0.0927 | 0.0927 | 0.8329 | 1.30 | 0.3316 | 2.91 | 5.60 | 919,091.60 | 3.90 | 4.96 | 5.37 | 6.88 | 38.89 | 41.41 | 11.76 | 13.74 | 1.05 | 16.36 | 0.3228 | 32.46 | 10.35 | 4.90 | 2.28 | -0.186 | -7.11 | 12.02 |
| SinoMab Bioscience Ltd | 28.54m | -349.79m | 1.85bn | 283.00 | -- | 2.96 | -- | 64.87 | -0.354 | -0.354 | 0.0289 | 0.6226 | 0.0264 | -- | -- | 100,850.90 | -32.38 | -- | -34.63 | -- | -- | -- | -1,225.57 | -- | -- | -27.17 | 0.3432 | -- | -- | -- | -135.07 | -- | -- | -- |
| Essex Bio-Technology Limited | 1.56bn | 323.01m | 1.86bn | 1.42k | 5.99 | 1.07 | 5.18 | 1.20 | 0.5427 | 0.5427 | 2.59 | 3.04 | 0.575 | 1.87 | 3.02 | 1,128,434.00 | 11.94 | 14.05 | 15.58 | 18.53 | 87.38 | 82.63 | 20.76 | 21.20 | 2.00 | 19.46 | 0.2272 | 15.57 | 67.43 | 16.12 | 58.03 | 20.48 | 47.87 | 24.31 |
| Antengene Corporation Ltd | 91.11m | -624.48m | 2.16bn | 329.00 | -- | 0.8875 | -- | 23.70 | -1.00 | -1.00 | 0.1465 | 3.66 | 0.0307 | 2.90 | 2.40 | 276,942.40 | -21.02 | -- | -22.36 | -- | 83.94 | -- | -685.39 | -- | 11.13 | -15.73 | 0.0156 | -- | -- | -- | 77.62 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -382.47m | 2.26bn | 515.00 | -- | 3.00 | -- | -- | -0.7433 | -0.7433 | 0.00 | 1.47 | 0.00 | -- | -- | 0.00 | -33.66 | -- | -37.53 | -- | -- | -- | -- | -- | 1.49 | -16.45 | 0.1291 | -- | -- | -- | 19.32 | -- | -- | -- |
| TOT Biopharm International Co Ltd | 259.06m | -178.36m | 2.30bn | 337.00 | -- | 5.11 | -- | 8.86 | -0.3101 | -0.3101 | 0.4504 | 0.5875 | 0.3254 | 1.65 | 5.17 | 768,737.60 | -22.41 | -- | -34.33 | -- | 73.14 | -- | -68.85 | -- | 0.8533 | -14.00 | 0.4296 | -- | 239.36 | -- | 9.46 | -- | -- | -- |
| Abbisko Cayman Ltd | -100.00bn | -100.00bn | 2.32bn | 160.00 | -- | 0.8473 | -- | -- | -- | -- | -- | 3.89 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0204 | -- | -- | -- | -156.14 | -- | -- | -- |
| Everest Medicines Ltd | 1.21m | -1.42bn | 2.62bn | 476.00 | -- | 0.4682 | -- | 2,166.27 | -4.84 | -4.84 | 0.0041 | 18.22 | 0.0002 | -- | 0.0911 | 2,986.04 | -19.03 | -- | -20.51 | -- | 64.75 | -- | -117,819.00 | -- | 2.36 | -39.74 | 0.0282 | -- | -- | -- | 82.17 | -- | -- | -- |
| Clover Biopharmaceuticals Ltd | 0.00 | -6.43bn | 2.63bn | 814.00 | -- | 13.49 | -- | -- | -12.36 | -12.36 | 0.00 | 0.1675 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.29 | -0.7857 | 0.3124 | -- | -- | -- | -559.03 | -- | -- | -- |
| VIVA Biotech Holdings | 2.41bn | 122.61m | 2.65bn | 2.13k | 21.26 | 0.6061 | 8.32 | 1.10 | -0.0098 | -0.0098 | 1.23 | 2.26 | 0.2723 | 7.54 | 4.76 | 1,132,157.00 | 1.49 | 2.39 | 1.72 | 2.63 | 31.09 | 37.43 | 5.47 | 10.18 | 1.51 | 0.9463 | 0.4168 | 22.00 | 201.90 | 85.23 | 174.32 | 63.68 | 138.39 | -- |
| Consun Pharmaceutical Group Ltd | 2.37bn | 700.78m | 2.70bn | 2.77k | 3.81 | 0.8871 | 3.43 | 1.14 | 0.8756 | 0.8756 | 2.96 | 3.77 | 0.5147 | 2.20 | 6.19 | 856,163.10 | 15.26 | 10.98 | 23.98 | 17.72 | 74.56 | 74.45 | 29.64 | 22.72 | 2.34 | -- | 0.1356 | 40.37 | 16.65 | 10.82 | 18.32 | 13.93 | 31.46 | 21.69 |
| Acotec Scientific Holdings Ltd | 373.31m | -39.04m | 2.78bn | 400.00 | -- | 2.06 | -- | 7.45 | -0.1933 | -0.1933 | 1.36 | 4.31 | 0.454 | 1.05 | 6.38 | 933,278.80 | -4.75 | -- | -5.86 | -- | 84.69 | -- | -10.46 | -- | 16.60 | -- | 0.025 | -- | 56.62 | -- | -80.37 | -- | -- | -- |
| Ascletis Pharma Inc | 86.51m | -194.05m | 2.90bn | 266.00 | -- | 0.9714 | -- | 33.55 | -0.1778 | -0.1778 | 0.0793 | 2.75 | 0.0273 | 0.2485 | 1.51 | 325,226.20 | -6.12 | -4.81 | -6.30 | -5.13 | 84.16 | 68.75 | -224.31 | -121.01 | 25.63 | -7.58 | 0.0006 | -- | 119.64 | 18.45 | 4.89 | -- | -30.57 | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 165.00m | -322.07m | 3.16bn | 262.00 | -- | 1.89 | -- | 19.12 | -0.4297 | -0.4297 | 0.22 | 2.16 | 0.0862 | -- | 1.44 | 629,766.20 | -16.83 | -- | -17.63 | -- | 11.42 | -- | -195.19 | -- | -- | -- | 0.0026 | -- | -68.58 | -- | 80.10 | -- | -- | -- |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 2.21bn | -124.92m | 3.64bn | 3.62k | -- | 0.5727 | 16.19 | 1.65 | -0.142 | -0.142 | 2.51 | 7.23 | 0.2033 | 1.87 | 3.35 | 610,663.60 | -1.15 | 10.68 | -1.59 | 14.87 | 67.02 | 82.48 | -5.65 | 27.10 | 0.4747 | 0.6063 | 0.3727 | 38.26 | -61.08 | -0.5958 | -170.00 | -- | 27.36 | -- |
Data as of Oct 05 2022. Currency figures normalised to Everest Medicines Ltd's reporting currency: Hong Kong Dollar HKD
22.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| RA Capital Management LPas of 18 Aug 2022 | 23.58m | 7.85% |
| Janchor Partners Ltd.as of 31 Dec 2020 | 17.42m | 5.80% |
| Wellington Management Co. LLPas of 21 Mar 2022 | 13.88m | 4.62% |
| Candriam Belgium SAas of 31 May 2022 | 5.47m | 1.82% |
| The Vanguard Group, Inc.as of 09 Sep 2022 | 2.53m | 0.84% |
| BlackRock Fund Advisorsas of 08 Sep 2022 | 1.60m | 0.53% |
| Wellington Management Singapore Pte Ltd.as of 03 Aug 2021 | 1.20m | 0.40% |
| Wellington Management Japan Pte Ltd.as of 21 Mar 2022 | 741.50k | 0.25% |
| Dimensional Fund Advisors LPas of 31 Aug 2022 | 547.50k | 0.18% |
| BlackRock Advisors LLCas of 31 Aug 2022 | 463.50k | 0.15% |
More ▼
Data from 21 Apr 2022 - 15 Aug 2022Source: FactSet Research Systems Inc.
